|
1
|
Longhi A, Errani C, De Paolis M, Mercuri M
and Bacci G: Primary bone osteosarcoma in the pediatric age: State
of the art. Cancer Treat Rev. 32:423–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ta HT, Dass CR, Choong PF and Dunstan DE:
Osteosarcoma treatment: State of the art. Cancer Metastasis Rev.
28:247–263. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–4153. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hughes DP: Strategies for the targeted
delivery of therapeutics for osteosarcoma. Exper Opin Drug Deliv.
6:1311–1321. 2009. View Article : Google Scholar
|
|
5
|
Ferguson WS and Goorin AM: Current
treatment of osteosarcoma. Cancer Invest. 19:292–315.. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dickey LL, Worne CL, Glover JL, Lane TE
and O'Connell RM: MicroRNA-155 enhances T cell trafficking and
antiviral effector function in a model of coronavirus-induced
neurologic disease. J Nueuroinflammation. 13:2402016. View Article : Google Scholar
|
|
7
|
Hammond SM: An overview of microRNAs. Adv
Drug Deliv Rev. 87:3–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Knirsh R, Ben Dror I, Modai S, Shomron N
and Vardimon L: MicroRNA 10b promotes abnormal expression of the
proto-oncogene c-Jun in metastatic breast cancer cells. Oncotarget.
7:59932–59944. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vychytilova-Faltejskova P, Radova L,
Sachlova M, Kosarova Z, Slaba K, Fabian P, Grolich T, Prochazka V,
Kala Z, Svoboda M, et al: Serum-based MicroRNA signatures in early
diagnosis and prognosis prediction of colon cancer. Carcinogenesis.
37:941–950. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Long Y, Wu Z, Yang X, Chen L, Han Z, Zhang
Y, Liu J, Liu W and Liu X: MicroRNA-101 inhibits the proliferation
and invasion of bladder cancer cells via targeting c-FOS. Mol Med
Rep. 14:2651–2656. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong Q, Li C, Che X, Qu J, Fan Y, Li X, Li
Y, Wang Q, Liu Y, Yang X and Qu X: MicroRNA-891b is an independent
prognostic factor of pancreatic cancer by targeting Cbl-b to
suppress the growth of pancreatic cancer cells. Oncotarget.
7:82338–82353. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mizuno K, Mataki H, Seki N, Kumamoto T,
Kamikawaji K and Inoue H: MicroRNAs in non-small cell lung cancer
and idiopathic pulmonary fibrosis. J Hum Genet. 62:57–65. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Karbasy SH, Taheriazam A, Mirghasemi A,
Sedaghati F, Shakeri M, Yahaghi E and Bahador R: Retracted Article:
Upregulation of miR-300 and downregulation of miR-125b act as
potential predictor biomarkers in progression, metastasis, and poor
prognosis of osteosarcoma. Tumour Biol. Sep 2–2015.(Epub ahead of
print). PubMed/NCBI
|
|
14
|
Zhang C, Hu Y, Wan J and He H:
MicroRNA-124 suppresses the migration and invasion of osteosarcoma
cells via targeting ROR2-mediated non-canonical Wnt signaling.
Oncol Rep. 34:2195–2201. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu R, Liu S, Chen H and Lao L:
MicroRNA-30a downregulation contributes to chemoresistance of
osteosarcoma cells through activating Beclin-1-mediated autophagy.
Oncol Rep. 35:1757–1763. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang W, Zhou X and Wei M: MicroRNA-144
suppresses osteosarcoma growth and metastasis by targeting ROCK1
and ROCK2. Oncotarget. 6:10297–10308. 2015.PubMed/NCBI
|
|
17
|
Lin Z, Song D, Wei H, Yang X, Liu T, Yan W
and Xiao J: TGF-β1-induced miR-202 mediates drug resistance by
inhibiting apoptosis in human osteosarcoma. J Cancer Res Clin
Oncol. 142:239–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Jia LS, Yuan W, Wu Z, Wang HB, Xu
T, Sun JC, Cheng KF and Shi JG: Low miR-34a and miR-192 are
associated with unfavorable prognosis in patients suffering from
osteosarcoma. Am J Transl Res. 7:111–119. 2015.PubMed/NCBI
|
|
19
|
Yun EJ, Song KS, Shin S, Kim S, Heo JY,
Kweon GR, Wu T, Park JI and Lim K: Docosahexaenoic acid suppresses
breast cancer cell metastasis by targeting
matrix-metalloproteinases. Oncotarget. 7:49961–49971. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tian X, Ye C, Yang Y, Guan X, Dong B, Zhao
M and Hao C: Expression of CD147 and matrix metalloproteinase-11 in
colorectal cancer and their relationship to clinicopathological
features. J Transl Med. 13:3372015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Al-Alem L and Curry TE Jr: Ovarian cancer:
Involvement of the matrix metalloproteinases. Reproduction.
150:R55–R64. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Basset P, Bellocq JP, Lefebvre O, Noël A,
Chenard MP, Wolf C, Anglard P and Rio MC: Stromelysin-3: A paradigm
for stroma-derived factors implicated in carcinoma progression.
Crit Rev Oncol Hematol. 26:43–53. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Unni KK and Dahlin DC: Grading of bone
tumors. Semin Diagn Pathol. 1:165–172. 1984.PubMed/NCBI
|
|
25
|
Varshney J and Subramanian S: MicroRNAs as
potential target in human bone and soft tissue sarcoma
therapeutics. Front Mol Biosci. 2:312015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fire A, Xu S, Montgomery MK, Kostas SA,
Driver SE and Mello CC: Potent and specific genetic interference by
double-stranded RNA in Caenorhabditis elegans. Nature. 391:806–811.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liang HQ, Wang RJ, Diao CF, Li JW, Su JL
and Zhang S: The PTTG1-targeting miRNAs miR-329, miR-300, miR-381,
and miR-655 inhibit pituitary tumor cell tumorigenesis and are
involved in a p53/PTTG1 regulation feedback loop. Oncotarget.
6:29413–29427. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jin Y, Lu J, Wen J, Shen Y and Wen X:
Regulation of growth of human bladder cancer by miR-192. Tumour
Biol. 36:3791–3797. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Geng L, Chaudhuri A, Talmon G, Wisecarver
JL, Are C, Brattain M and Wang J: MicroRNA-192 suppresses liver
metastasis of colon cancer. Oncogene. 33:5332–5340. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu F, Meng X, Tong Q, Liang L, Xiang R,
Zhu T and Yang S: BMP-6 inhibits cell proliferation by targeting
microRNA-192 in breast cancer. Biochim Biophys Acta.
1832:2379–2390. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xiang M, Zeng Y, Yang R, Xu H, Chen Z,
Zhong J, Xie H, Xu Y and Zeng X: U6 is not a suitable endogenous
control for the quantification of circulating microRNAs. Biochem
Biophys Res Commun. 454:210–214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li S, Li F, Niu R, Zhang H, Cui A, An W
and Wang X: Mir-192 suppresses apoptosis and promotes proliferation
in esophageal aquamous cell caicinoma by targeting Bim. Int J Clin
Exp Pathol. 8:8048–8056. 2015.PubMed/NCBI
|
|
36
|
Zhao C, Zhang J, Zhang S, Yu D, Chen Y,
Liu Q, Shi M, Ni C and Zhu M: Diagnostic and biological
significance of microRNA-192 in pancreatic ductal adenocarcinoma.
Oncol Rep. 30:276–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Okada A, Saez S, Misumi Y and Basset P:
Rat stromelysin 3: cDNA cloning from healing skin wound, activation
by furin and expression in rat tissues. Gene. 185:187–193. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Brennecke J, Stark A, Russell RB and Cohen
SM: Principles of microRNA-target recognition. PLoS Biol.
3:e852015. View Article : Google Scholar
|
